antineoplastic agents, hormonal

Preferred Label : antineoplastic agents, hormonal;

MeSH definition : Antineoplastic agents that are used to treat hormone-sensitive tumors. Hormone-sensitive tumors may be hormone-dependent, hormone-responsive, or both. A hormone-dependent tumor regresses on removal of the hormonal stimulus, by surgery or pharmacological block. Hormone-responsive tumors may regress when pharmacologic amounts of hormones are administered regardless of whether previous signs of hormone sensitivity were observed. The major hormone-responsive cancers include carcinomas of the breast, prostate, and endometrium; lymphomas; and certain leukemias. (From AMA Drug Evaluations Annual 1994, p2079);

MeSH synonym : hormonal antineoplastics; hormonal antineoplastic drugs; hormonal agents, antineoplastic; agents, antineoplastic hormonal; hormonal antineoplastic agents; antineoplastic hormonal drugs; drugs, antineoplastic hormonal; hormonal drugs, antineoplastic; antineoplastics, hormonal; antineoplastic hormonal agents; antineoplastic drugs, hormonal;

MeSH annotation : consider also NEOPLASMS, HORMONE-DEPENDENT /drug ther;

Is substance : O;

action pharmacologique : O;

Details

Origin ID

D018931;

UMLS CUI

C0282559;

ATC code(s)
- estrogens [ATC Code]
- progestogens [ATC Code]
ATC code(s)
- diethylstilbestrol [ATC Code]
- estrogens [ATC Code]
- ethinylestradiol [ATC Code]
- gonadotropin releasing hormone analogues [ATC Code]
- hormones and related agents [ATC Code]
- medroxyprogesterone [ATC Code]
- megestrol [ATC Code]
- other hormones [ATC Code]
- progestogens [ATC Code]
- tamoxifen [ATC Code]
Allowable qualifiers
- administration and dosage [MeSH Qualifier]
- adverse effects [MeSH Qualifier]
- agonists [MeSH Qualifier]
- analysis [MeSH Qualifier]
- antagonists and inhibitors [MeSH Qualifier]
- blood [MeSH Qualifier]
- cerebrospinal fluid [MeSH Qualifier]
- chemical synthesis [MeSH Qualifier]
- chemistry [MeSH Qualifier]
- classification [MeSH Qualifier]
- contraindications [MeSH Qualifier]
- economics [MeSH Qualifier]
- history [MeSH Qualifier]
- immunology [MeSH Qualifier]
- isolation and purification [MeSH Qualifier]
- metabolism [MeSH Qualifier]
- pharmacokinetics [MeSH Qualifier]
- pharmacology [MeSH Qualifier]
- poisoning [MeSH Qualifier]
- radiation effects [MeSH Qualifier]
- standards [MeSH Qualifier]
- supply and distribution [MeSH Qualifier]
- therapeutic use [MeSH Qualifier]
- toxicity [MeSH Qualifier]
- urine [MeSH Qualifier]
Currated CISMeF NLP mapping
- Antineoplastic Hormonal/Endocrine Agent [NCIt concept]
Indexing information
- 9-fluoro-16alpha-methyl-11,17-dihydroxy-3-oxo-1,4-androstadiene-17beta-carboxylic acid [MeSH Supplementary Concept]
- ethyl 3-(5-(2-ethoxycarbonyl-1-methylvinyloxy)-1-methyl-1H-indol-3-y)but-2-enoate [MeSH Supplementary Concept]
- luprolide acetate gel depot [MeSH Supplementary Concept]
- nomegestrol [MeSH Supplementary Concept]
- nomegestrol acetate [MeSH Supplementary Concept]
Metaterm(s)
- endocrinology [CISMeF Metaterm]
Ne pas confondre avec
- anticarcinogenic agents [MeSH Descriptor]
Record concept(s)
- antineoplastic agents, hormonal [MeSH concept]
See also
- neoplasms, hormone-dependent [MeSH Descriptor]
See also (suggested by CISMeF)
- diethylstilbestrol [MeSH Descriptor]
- hormones [MeSH Descriptor]
- progesterone congeners [MeSH Descriptor]
Semantic type(s)
- Pharmacologic Substance [UMLS semantic type]
Substance(s)
- Anastrozole [MeSH Descriptor]
- Fulvestrant [MeSH Descriptor]
- KW 2189 [MeSH Supplementary Concept]
- aminoglutethimide [MeSH Descriptor]
- chlorotrianisene [MeSH Descriptor]
- dexamethasone [MeSH Descriptor]
- dienogest [MeSH Supplementary Concept]
- estramustine [MeSH Descriptor]
- fadrozole [MeSH Descriptor]
- flutamide [MeSH Descriptor]
- fosfestrol [MeSH Supplementary Concept]
- goserelin [MeSH Descriptor]
- hexestrol [MeSH Descriptor]
- leukoregulin [MeSH Supplementary Concept]
- leuprolide [MeSH Descriptor]
- liarozole [MeSH Supplementary Concept]
- medrogestone [MeSH Descriptor]
- medroxyprogesterone acetate [MeSH Descriptor]
- megestrol [MeSH Descriptor]
- megestrol acetate [MeSH Descriptor]
- methylprednisolone hemisuccinate [MeSH Descriptor]
- methyltestosterone [MeSH Descriptor]
- mitotane [MeSH Descriptor]
- nafoxidine [MeSH Descriptor]
- octreotide [MeSH Descriptor]
- prednisolone [MeSH Descriptor]
- prednisone [MeSH Descriptor]
- tamoxifen [MeSH Descriptor]
- testolactone [MeSH Descriptor]
- tibolone [MeSH Supplementary Concept]
- toremifene [MeSH Descriptor]
- triptorelin pamoate [MeSH Descriptor]
UMLS correspondences (same concept)
- Antineoplastic Hormonal/Endocrine Agent [NCIt concept]

Keyword's position in hierarchy(ies) :

Main resources

You can consult :

recommendations
documents concerning education
documents for patients